Gang Dong

1.3k total citations
24 papers, 1.0k citations indexed

About

Gang Dong is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Gang Dong has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Gang Dong's work include Cancer, Hypoxia, and Metabolism (4 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Gang Dong is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Gang Dong collaborates with scholars based in China, United States and Ethiopia. Gang Dong's co-authors include Louise T. Chow, Thomas R. Broker, Carter Van Waes, Ning T. Yeh, Zhong Chen, C C Bancroft, Chih‐Ming Chiang, Jiefeng Cui, Dongmei Gao and Nilanjan Ray and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Journal of Virology.

In The Last Decade

Gang Dong

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gang Dong China 14 443 232 220 182 182 24 1.0k
Kai‐Fu Tang China 19 548 1.2× 280 1.2× 197 0.9× 244 1.3× 327 1.8× 48 1.1k
Mary C. Stevenson United States 12 395 0.9× 135 0.6× 289 1.3× 105 0.6× 97 0.5× 14 869
Barbara Franceschini Italy 21 437 1.0× 111 0.5× 239 1.1× 378 2.1× 160 0.9× 56 1.2k
Zhijian Duan United States 20 791 1.8× 162 0.7× 224 1.0× 348 1.9× 312 1.7× 39 1.4k
Yuemeng Jia United States 14 747 1.7× 122 0.5× 118 0.5× 107 0.6× 259 1.4× 18 1.2k
Cyrill Géraud Germany 21 476 1.1× 280 1.2× 252 1.1× 342 1.9× 143 0.8× 73 1.4k
Qinghua Cao China 19 444 1.0× 198 0.9× 268 1.2× 103 0.6× 232 1.3× 71 1.2k
Laurent Mailly France 16 732 1.7× 434 1.9× 171 0.8× 346 1.9× 150 0.8× 25 1.4k
Yuanguo Wang China 15 295 0.7× 155 0.7× 185 0.8× 118 0.6× 154 0.8× 37 852

Countries citing papers authored by Gang Dong

Since Specialization
Citations

This map shows the geographic impact of Gang Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gang Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gang Dong more than expected).

Fields of papers citing papers by Gang Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gang Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gang Dong. The network helps show where Gang Dong may publish in the future.

Co-authorship network of co-authors of Gang Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Gang Dong. A scholar is included among the top collaborators of Gang Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gang Dong. Gang Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Gang, et al.. (2022). Increased PD‐L1 Restricts Liver Injury in Nonalcoholic Fatty Liver Disease. Oxidative Medicine and Cellular Longevity. 2022(1). 5954437–5954437. 9 indexed citations
2.
Wu, Jie, Lulu Sun, Tingting Liu, & Gang Dong. (2021). Ultrasound-Targeted Microbubble Destruction-Mediated Downregulation of EZH2 Inhibits Stemness and Epithelial-Mesenchymal Transition of Liver Cancer Stem Cells. OncoTargets and Therapy. Volume 14. 221–237. 11 indexed citations
3.
Dong, Gang, Xiaoquan Huang, Yuli Zhu, et al.. (2021). Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis. Annals of Translational Medicine. 9(4). 289–289. 18 indexed citations
4.
Dong, Gang, et al.. (2021). SREBF2 triggers endoplasmic reticulum stress and Bax dysregulation to promote lipopolysaccharide-induced endothelial cell injury. Cell Biology and Toxicology. 38(1). 185–201. 6 indexed citations
5.
Dong, Gang, Xiaoquan Huang, Siyu Jiang, et al.. (2020). SCAP Mediated GDF15-Induced Invasion and EMT of Esophageal Cancer. Frontiers in Oncology. 10. 564785–564785. 12 indexed citations
6.
Liu, Jie, Gang Dong, Huan Xia, et al.. (2020). Preliminary research on the effects and mechanisms of umbilical cord‑derived mesenchymal stem cells in streptozotocin‑induced diabetic retinopathy. International Journal of Molecular Medicine. 46(2). 849–858. 7 indexed citations
7.
Dong, Gang, Xiahui Lin, Dongmei Gao, et al.. (2019). Intermittent hypoxia alleviates increased VEGF and pro‑angiogenic potential in liver cancer cells. Oncology Letters. 34 indexed citations
8.
Dong, Gang, Qiongdan Zheng, Min Ma, et al.. (2018). Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15. Cancer Medicine. 7(3). 820–830. 35 indexed citations
9.
Dong, Gang, Min Ma, Xiahui Lin, et al.. (2018). Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15. Experimental Cell Research. 370(2). 468–477. 22 indexed citations
10.
Zhang, Rui, Rongrong Yao, Jinghuan Li, et al.. (2017). Activated hepatic stellate cells secrete periostin to induce stem cell-like phenotype of residual hepatocellular carcinoma cells after heat treatment. Scientific Reports. 7(1). 2164–2164. 30 indexed citations
11.
Zhang, Rui, Min Ma, Gang Dong, et al.. (2017). Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment. Cancer Science. 108(9). 1778–1786. 40 indexed citations
12.
Chang, Wenguang, et al.. (2017). Hepatic fibrosis and supersonic shear imaging in patients with different etiological chronic hepatic diseases.. PubMed. 30(3). 761–765. 3 indexed citations
13.
Li, Jinchao, Gang Dong, Xiaowei Yu, et al.. (2013). Genistein: the potential for efficacy in rheumatoid arthritis. Clinical Rheumatology. 32(5). 535–540. 48 indexed citations
14.
Bhattacharya, Samir, Gang Dong, Darren P. Baker, et al.. (2012). Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses. Oncogene. 32(36). 4214–4221. 51 indexed citations
15.
Palker, T J, Gang Dong, & Wolfgang W. Leitner. (2009). Mast cells in innate and adaptive immunity to infection. European Journal of Immunology. 40(1). 13–18. 11 indexed citations
16.
Dong, Gang, Nilanjan Ray, & Scott T. Acton. (2005). Intravital leukocyte detection using the gradient inverse coefficient of variation. IEEE Transactions on Medical Imaging. 24(7). 910–924. 47 indexed citations
17.
18.
Dong, Gang, et al.. (2001). Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.. PubMed. 61(15). 5911–8. 228 indexed citations
19.
Wolf, Jeffrey S., Zhong Chen, Gang Dong, John B. Sunwoo, & Carter Van Waes. (1999). The role of IL‐1a in growth and autocrine expression of proangiogenic cytokine IL‐8 in HNSCC. Otolaryngology. 121(S2). 1 indexed citations
20.
Schulick, Andrew H., Allen J. Taylor, Gang Dong, et al.. (1998). Overexpression of transforming growth factor β1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proceedings of the National Academy of Sciences. 95(12). 6983–6988. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai‐Fu Tang Breakdown of academic impact, for papers by Mary C. Stevenson Breakdown of academic impact, for papers by Barbara Franceschini Breakdown of academic impact, for papers by Zhijian Duan Breakdown of academic impact, for papers by Yuemeng Jia Breakdown of academic impact, for papers by Cyrill Géraud Breakdown of academic impact, for papers by Qinghua Cao Breakdown of academic impact, for papers by Laurent Mailly Breakdown of academic impact, for papers by Yuanguo Wang
Rankless by CCL
2026